These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6194144)

  • 1. Tissue concentrations of mezlocillin in benign hypertrophy of the prostate following intravenous bolus injection versus infusion.
    Naber KG; Adam D
    J Antimicrob Chemother; 1983 May; 11 Suppl C():17-23. PubMed ID: 6194144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue concentrations of mezlocillin in prostate adenomas following intravenous bolus injections and continuous infusions].
    Naber K; Adam D
    Fortschr Med; 1983 Nov; 101(41):1862-8. PubMed ID: 6197351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azlocillin and mezlocillin concentration in human prostatic tissue.
    Smith RP; Wilbur HJ; Bassey C; Baltch AL
    Chemotherapy; 1988; 34(4):267-71. PubMed ID: 3208544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM; Lunz JC; Kees F; Wieland W; Naber KG
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HPLC study of the pharmacokinetics of mezlocillin administered by 30-minute infusion and comparison with the direct intravenous route].
    Jehl F; Peter JD; Monteil H; Dupeyron JP; Minck R
    Pathol Biol (Paris); 1984 May; 32(5):312-7. PubMed ID: 6739140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
    Naber KG; Sörgel F; Kees F; Schumacher H; Sigl G; Zürcher J; Berger S
    Infection; 1989; 17 Suppl 1():S30-6. PubMed ID: 2478481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1991 Jun; 37(6):659-62. PubMed ID: 1716410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A pharmacokinetic study of diffusion in adenomatous prostatic tissue of an intravenous bolus of cefamandole].
    Billebaud T; Astier L; Rutkowski A; Boccon-Gibod L
    Ann Urol (Paris); 1990; 24(2):141-5. PubMed ID: 1693483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion.
    Ohlsson H; Bergan T
    Arzneimittelforschung; 1979; 29(12a):1958-9. PubMed ID: 543900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of a single infusion of ampicillin and sulbactam into prostatic tissue during transurethral prostatectomy.
    Klotz T; Braun M; Bin Saleh A; Orlovski M; Engelmann U
    Int Urol Nephrol; 1999; 31(2):203-9. PubMed ID: 10481965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of prostatic tissue levels of cefbuperazone].
    Izumi H; Ikeda S; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1987 Aug; 33(8):1316-8. PubMed ID: 2447766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of ceftriaxone in prostate adenoma tissue.
    Adam D; Naber KG
    Chemotherapy; 1984; 30(1):1-6. PubMed ID: 6198127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the concentration of cefminox sodium in serum and prostatic tissue].
    Sasagawa I
    Hinyokika Kiyo; 1990 Jun; 36(6):737-9. PubMed ID: 1700586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cefixime concentration in human prostatic tissue following 3-days of administration].
    Morita M; Nakagawa H; Suzuki K
    Hinyokika Kiyo; 1991 Nov; 37(11):1581-4. PubMed ID: 1722638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the prostatic tissue levels of cefmenoxime (CMX)].
    Kataoka K; Kaneko S; Kurita T
    Hinyokika Kiyo; 1985 Feb; 31(2):273-9. PubMed ID: 2409786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.
    Meyers BR; Srulevitch ES; Sacks HS; Hirschman SZ; Worner TM; Wormser GP; Jacobson J
    J Antimicrob Chemother; 1986 Dec; 18(6):709-13. PubMed ID: 3818496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfer of ceftizoxime into serum and prostatic tissue].
    Fujisawa M; Mizunaga M; Arima S; Tokunaka S; Inada F; Takamura T; Yachiku S
    Hinyokika Kiyo; 1985 Oct; 31(10):1855-9. PubMed ID: 2418658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.